Zydus Lifesciences Ltd., formerly known as Cadila Healthcare, is a leading pharmaceutical company based in India, recognized for its commitment to innovation and healthcare excellence. The company specializes in the development, manufacturing, and distribution of a broad spectrum of pharmaceutical products including generics, specialty formulations, vaccines, and biosimilars. Focused on improving global healthcare outcomes, Zydus has a diversified portfolio that encompasses therapies for cardiovascular diseases, gastroenterology, and diabetes, among others. Zydus Lifesciences plays a pivotal role in both domestic and international markets, providing accessible healthcare solutions across over 50 countries. The company's extensive research and development capabilities highlight its dedication to advancing medical science, supported by several state-of-the-art facilities worldwide. Notably, its focus on affordable healthcare aligns with the rising demand for cost-effective medicines globally. In the financial market, Zydus Lifesciences is significant as a key player in the pharmaceutical sector, representing a crucial segment of India's healthcare industry. Its innovation-led approach and robust product pipeline foster sustained growth and reinforce its role as a healthcare leader.